Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (PCR-Fluorescence Probing)

The Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit is developed for qualitative detection of 2019-nCoV that is collected from human nasopharyngeal swabs, sputum and bronchoalveolar lavage fluid in vitro. It is only used as an in vitro diagnostic emergency response for 2019-nCoV infection happened in December 2019. It is suggested to follow the newest document instructions of “Diagnosis and treatment of novel coronavirus infection pneumonia” and “Strategic Preparation and Response Plan of novel coronavirus infection pneumonia” (current version). The novel coronaviruses belong to the β genus. 2019-nCoV is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. The novel coronavirus detection should meet the requirements of "new laboratory technology related to new coronavirus pneumonia detection guidelines" and address biosafety issues